Ho Sheila

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA.

Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA.

Viewray Technologies, Inc. develops radiation therapy technology for the treatment of cancer. It operates through the MRIdian system software. The company was founded by James F. Dempsey and Russell S. Donda in March 2004 and is headquartered in Oakwood Village, OH.

P2 Science, Inc. operates as a specialty chemical biorefinery company. It offers cosmetics and personal care, flavors and fragrances, specialty materials, and bioactives. The company was founded by Neil A. Burns, Paul Anastas, and Patrick Foley in 2011 and is headquartered in Woodbridge, CT.

Kenexa Compensation, Inc. develops skills management software for human capital management. The firm offers software applications and proprietary content that help executives, line managers, and compensation professionals automate, streamline, and optimize critical talent management processes including market pricing, compensation planning, performance management, competency management, and succession planning. The company was founded by Kent Plunkett in 1999 and is headquartered in Wayne, PA.

LanzaTech, Inc. provides gas fermentation services. Its converts carbon rich wastes and residues produced by industries such as steel manufacturing, oil refining, and chemical production into fuel ethanol. The company was founded by Sean Dennis Simpson in 2005 and is headquartered in Skokie, IL.

Cerca Insights Sdn. Bhd. provides behavioral pharmacology paradigms to research institutes. It services include phenotyping new rodent models, sar support, identifying and optimising leads, behavioural assay development, PK screens and PD analysis, early safety assessment, ageing studies and chronic dosing. The company was founded by Anil K. Ratty in 2008 and is headquartered in Bayan Lepas, Malaysia.

Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia.

Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada.

Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria.

Functional Enviromics Technologies SA provides biotechnology solutions. It develops chemically defined cell culture media for life sciences research institutions and industries. The firm offers cell functional enviromics (CFE) sciences and derived technologies. Its CFE technology engineers cellular metabolism which enables increased cell culture performance and decreases development time for media formulation. The company was founded by Rui Oliveira, Inês Isidro, João Dias, Nuno Carinhas, Filipe Ataíde, and Ana Ferreira in 2013 and is headquartered in Caparica, Portugal.

Xeraya Capital Sdn. Bhd. (Xeraya Capital) is a venture capital firm founded in 2006 by Amirul Fares Wan Zahir. The firm is headquartered in Kuala Lumpur, Malaysia.

Baysient LLC is a private company that creates cloud-based software to facilitate individualized dosing of anti-inflammatory mabs to improve outcomes in patients. The company is based in Fort Myers, FL. The software uses Bayesian models, routine lab results, and demographics to individualize dosing to a specified target trough-level output to a PK dashboard. Steven A. Molnar has been the CEO of the company since 2019.

Khazanah Nasional Bhd. (Private Equity) (Khazanah Nasiona) is a Private Equity firm, a subsidiary of Khazanah Nasional Bhd. founded in 1994. The firm is headquartered in Malaysia.

Ancom Crop Care Sdn. Bhd. manufactures agrochemical product. Its products include fertilizers, flowering stimulant, foliar, fungicide, herbicide, insecticide, biopesticide, nematicide, molluscide, rodenticide and wetting agent. The company was founded in 1969 and is headquartered in Shah Alam, Malaysia.

The Carlyle Group LP (Global Private Equity) is a private equity firm founded in the year 1990 by William E. Conway, Jr. and Daniel A. D'Aniello. The firm is headquartered in Washington DC.